Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3505075

Beta release

Statistics of Fremanezumab in individuals with chronic migraine who had inadequate response to onabotulinumtoxinA and topiramate or valproic acid
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0900
2024-1000
2024-1100